论文信息 - Clinical trials with investigational medicinal products consisting of or containing genetically modified organisms: implementation of Clinical Trials Regulation EU 536/2014 - 字舞流文

Clinical trials with investigational medicinal products consisting of or containing genetically modified organisms: implementation of Clinical Trials Regulation EU 536/2014

V. Acha | T. Ruppert | S. Beattie | K. Wonnacott | A. Galaup | F. Montes | Pär Tellner | A. Persson | N. Lambot | Jacquelyn Awigena-Cook | C. Holzhauser | Julien Romanetto | Tobias Fleischmann | T. Reimer | Beatrix Friedeberg | Shera Dandapat | Caroline Correas | Silvia Garcia

[1] V. Acha,et al. Call for More Effective Regulation of Clinical Trials with Advanced Therapy Medicinal Products Consisting of or Containing Genetically Modified Organisms in the European Union. , 2021, Human gene therapy.

[2] W. Harwood,et al. Impacts of the EU GMO regulatory framework for plant genome editing , 2018, Food and energy security.

[3] EXECUTIVE SUMMARY COMMISSION STAFF WORKING DOCUMENT Study on the status of new genomic techniques under Union law and in light of the Court of Justice ruling in Case C-528 / 16 , 2021 .

[4] Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions an Eu Strategy on Adaptation to Climate Change , 2022 .